The University of Kentucky Markey Cancer Center and UK College of Pharmacy welcome clinical pharmacologist Dr. Jill Kolesar to their respective teams.

Dr. Gregory Bix has been named an adjunct associate professor in the School of Biomedical Sciences at the Queensland University of Technology.

Markey's Breast Translational Group is currently developing a proposed clinical trial that could create a major shift in the way triple-negative breast cancers are treated.

Six teams of researchers and physician scientists have become the inaugural recipients of pilot funding from the new Multidisciplinary Value Program (MVP).

More than 200 scientists and clinical investigators gathered to share insights and learn more about translational and clinical neuroscience research underway at the UK.

The clinical nurse specialist (CNS) track at the UK College of Nursing trains nursing professionals to act as experts, leaders and transformers of health systems in clinical care settings.

The Sanders-Brown Center on Aging Alzheimer's Disease Center has been awarded an $8.25 million, five-year grant from the National Institutes of Health (NIH) to continue and further research and clinical initiatives geared toward treating Alzheimer's disease.

As part of the screening for a UK research study, Angelique Bell had to do bloodwork and an EKG — standard tests to get baseline health data. Her results, however, were anything but standard: they showed extremely low levels of potassium and an arrhythmia in her heart that could be fatal if not treated.

Dr. Rachel Miller is one of 13 recipients of this year's National Cancer Institute Cancer Clinical Investigator Team Leadership Award.

Brittany Martin is leading a project to determine whether regular community screenings and targeted follow-up can help to identify undiagnosed cases, measurably improve health, and reduce the emotional and economic burden of diabetes through connection with local resources.